Waiting for BEMT: Industry Readies for Possible New Sunscreen Filter

Among the most buzzworthy topics in dermatology circles in the US (and at the recent American Academy of Dermatology [AAD] annual meeting in Denver, CO) is the potential availability of a new ultraviolet (UV) filter for sunscreen… finally.
No new sunscreen filter has been approved by the US Food & Drug Administration (FDA) since… wait for it… 1999, leaving the US lagging behind other countries in sunscreen innovation. The US regulates sunscreens as drugs, and that creates a different pathway with more requirements for new active ingredients, which is why it’s been such a slow build. But the wait is over…almost.
Bemotrizinol (BEMT) is now being considered for approval in the US. On December 11, 2025, the FDA released a formal proposal to add BEMT to the list of approved active ingredients for over-the-counter sunscreens, stating that it provides protection against both UVA and UVB rays, has low levels of systemic absorption, and rarely causes skin irritation.

What’s Next?

The public comment period was open from December 12, 2025, through January 26, 2026. If the FDA concludes that the comments support the proposal, they will issue a final order approving BEMT for use in US sunscreens and recommending its use for adults and children aged 6 months and older. BEMT is already approved in Europe, along with other filters not approved here: Tinosorb M (Bisoctrizole), Uvinul A Plus, Mexoryl SX (Ecamsule), Mexoryl XL (Drometrizole Trisiloxane), and the newer TriAsor.

There’s been a flurry of research on BEMT as companies await the FDA’s final decision. One study, which was presented at the 2026 AAD meeting,  examined ways to maximize the potential impact of excipients (thickener, emulsifier, film former, and oil absorbent) and formula design on the in vitro UV absorption efficacy, particularly UVA (320–400 nm), of sunscreens with BEMT.
For the study, researchers designed oil-in-water emulsions with comparable sensorial attributes and viscosities and compared them using in vitro spectroscopy. The formulas were designed with different excipients but contained the same UV filters and solubilizers, including 6% BEMT.
Key structural formula ingredients, such as thickeners, emulsifiers, film formers, and solid oil absorbents, their chemical characteristics, and concentrations in the formula play a key role in achieving high UV protection efficacy in sunscreen formulas.
Both UVA (320–400 nm) and UVB (290–320 nm) absorbance were observed to be highly dependent on formula composition, but the balance between absorbance capacity in the two regions was highly consistent, the study showed.
The optimization of excipients resulted in a three-fold increase in SPF. This SPF increase was achieved while maintaining the broad-spectrum behavior, indicated by consistent critical wavelength values (376–378 nm) and UVA:UVB absorption ratio (2.29–2.33), the researchers report.
“These findings demonstrate the importance of non-active excipients in sunscreen formulations containing BEMT to achieve high levels of sun protection,” they conclude. “Carefully designed formulations are required to fully optimize the UV protective capacity of BEMT in sunscreens.”

Experts React to The Possibility of a New UV Filter in The US

“I am excited about the potential approval of BEMT as a UV filter,” says Heather Woolery-Lloyd, MD, FAAD, Director of the Skin of Color Division in the Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery at the
University of Miami Miller School of Medicine  in Miami, FL. ” It will be the first new sunscreen filter approved in the US in over 20 years.  I love that it offers broad-spectrum protection.  With this new filter, I am looking forward to more sunscreen options for my patients.”
“I am excited about the potential approval of BEMT (bemotrizinol), and I would consider it a meaningful step for sun protection in the US as this would be the first new UV filter approved in the US in over two decades,” says Marisa Garshick, MD, FAAD, a Dermatologist in New York City. “It is a great addition as it is a highly photostable, broad-spectrum UV filter, meaning it protects against both UVA and UVB rays, allowing for reliable UV protection. It has already been used and shown to be safe and well-tolerated in other countries. From a formulation standpoint, it can be used to create elegant, lightweight sunscreens, which make compliance easier.”
Sandra Marchese Johnson, MD, FAAD, a Dermatologist at Johnson Dermatology in Fort Smith, AR, agrees. “I am a firm believer in mineral sunscreen because I think they work better. However, they are not elegant, and they do not get used as much as regular sunscreen, which is chemical sunscreen because they are not as elegant to use,” she shares. “I am hopeful that this new ingredient, which will act as a physical barrier, but be more cosmetically elegant, will allow people to use more of a good sunscreen.”

Jane Yoo, MD, MPP, FAAD, FACMS, is a Dermatologist and Mohs Surgeon in New York City and a Spokesperson for the Skin Cancer Foundation. “I am very excited about the potential approval of BEMT as a UV filter in the US because it gives dermatologists and patients access to another modern, photostable, broad-spectrum sunscreen filter that has already been used in many formulations internationally. We now have the opportunity to create sunscreens that are not only effective, but are also more wearable and cosmetically elegant. That matters because the best sunscreen is the one patients will use consistently, and better daily use means better long-term protection against UV damage, premature aging, and skin cancer.”